While Cigna has been rebuffed for acquisitions in the past due to antitrust concerns, experts say a potential deal between the two private payers this time has some legs.

Phone
While Cigna has been rebuffed for acquisitions in the past due to antitrust concerns, experts say a potential deal between the two private payers this time has some legs.